Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pluri (GB:0KJI)
LSE:0KJI
Pluri (0KJI) Share Price & Analysis
0 Followers
0KJI Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Pluri News
0KJI FAQ
What was Pluri’s price range in the past 12 months?
Currently, no data Available
What is Pluri’s market cap?
Currently, no data Available
When is Pluri’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Pluri’s earnings last quarter?
Currently, no data Available
Is Pluri overvalued?
According to Wall Street analysts Pluri’s price is currently same.
Does Pluri pay dividends?
Pluri does not currently pay dividends.
What is Pluri’s EPS estimate?
Pluri’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pluri have?
Currently, no data Available
What happened to Pluri’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Pluri?
Among the largest hedge funds holding Pluri’s share is ARK Investment Management LLC. It holds Pluri’s shares valued at N/A.
---
Company Description
Pluri
Pluristem Therapeutics, Inc. engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. It focuses on the development, clinical trials and manufacturing of cell therapeutics and related technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.
---
0KJI Stock 12 Months Forecast
Average Price Target
―---